Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Hempel, Casper ^a   Hyttel, Poul ^b   Staalsø, Trine ^a   Nyengaard, Jens R ^b   Kurtzhals, Jørgen A L ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cerebral malaria; Demyelination; Erythropoietin; Neurological sequelae; Plasmodium berghei ANKA

Indexed keywords

MYELIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORPUS CALLOSUM; FEMALE; MORPHOLOGY; MOUSE; MYELIN SHEATH; NONHUMAN; PLASMODIUM BERGHEI INFECTION; STEREOLOGY; THICKNESS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CORPUS CALLOSUM; ERYTHROPOIETIN; FEMALE; HUMANS; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON; MYELIN SHEATH; NEUROPROTECTIVE AGENTS; PLACEBOS; PLASMODIUM BERGHEI; TREATMENT OUTCOME;

EID: 84862771113     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-216     Document Type: Article

References (53)

1. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Hunt NH, Grau GE, Trends Immunol 2003 24 491 499 10.1016/S1471-4906(03) 00229-1 12967673
2. Cognitive impairment after cerebral malaria in children: a prospective study. Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, John CC, Pediatrics 2007 119 360 e366 10.1542/peds.2006-2027 17224457
3. Cerebral Malaria in children is associated with long-term cognitive impairment. John CC, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, Wu B, Boivin MJ, Pediatrics 2008 122 92 99 10.1542/peds.2007-2258 18595991
4. Cerebral calpain in fatal falciparum malaria. Medana IM, Day NP, Hien TT, Mai NT, Bethell D, Phu NH, Turner GD, Farrar J, White NJ, Esiri MM, Neuropathol Appl Neurobiol 2007 33 179 192 10.1111/j.1365-2990.2006.00777.x 17359359
5. Cellular stress and injury responses in the brains of adult Vietnamese patients with fatal Plasmodium falciparum malaria. Medana IM, Mai NT, Day NP, Hien TT, Bethell D, Phu NH, Farrar J, White NJ, Turner GD, Neuropathol Appl Neurobiol 2001 27 421 433 10.1046/j.0305-1846.2001.00360.x 11903925
6. Axonal injury in cerebral malaria. Medana IM, Day NP, Hien TT, Mai NT, Bethell D, Phu NH, Farrar J, Esiri MM, White NJ, Turner GD, Am J Pathol 2002 160 655 666 10.1016/S0002-9440(10)64885-7 11839586
7. The neuropathology of fatal cerebral malaria in Malawian children. Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D, Kamiza S, Molyneux M, Taylor TE, Am J Pathol 2011 178 2146 2158 10.1016/j.ajpath.2011.01. 016 21514429
8. Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Ma N, Madigan MC, Chan-Ling T, Hunt NH, Glia 1997 19 135 151 10.1002/(SICI)1098-1136(199702)19:2<135:: AID-GLIA5>3.0.CO;2-# 9034830
9. Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages. Lackner P, Burger C, Pfaller K, Heussler V, Helbok R, Morandell M, Broessner G, Tannich E, Schmutzhard E, Beer R, Neuropathol Appl Neurobiol 2007 33 560 571 17442059
10. Behavioural and histopathological alterations in mice with cerebral malaria. Lackner P, Beer R, Heussler V, Goebel G, Rudzki D, Helbok R, Tannich E, Schmutzhard E, Neuropathol Appl Neurobiol 2006 32 177 188 10.1111/j.1365-2990. 2006.00706.x 16599946
11. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. Desruisseaux MS, Gulinello M, Smith DN, Lee SC, Tsuji M, Weiss LM, Spray DC, Tanowitz HB, J Infect Dis 2008 197 1621 1627 10.1086/587908 18419550
12. Challenges in the determination of early predictors of cerebral malaria: lessons from the human disease and the experimental murine models. Martins YC, Carvalho LJ, niel-Ribeiro CT, Neuroimmunomodulation 2009 16 134 145 10.1159/000180268 19212133
13. Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria. Dai M, Reznik SE, Spray DC, Weiss LM, Tanowitz HB, Gulinello M, Desruisseaux MS, Microbes Infect 2010 12 1198 1207 10.1016/j.micinf.2010.08.006 20800692
14. A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria. Carroll RW, Wainwright MS, Kim KY, Kidambi T, Gomez ND, Taylor T, Haldar K, PLoS One 2010 5 13124 10.1371/journal.pone.0013124 20957049
15. Axonal damage: a key predictor of outcome in human CNS diseases. Medana IM, Esiri MM, Brain 2003 126 515 530 10.1093/brain/awg061 12566274
16. Cerebral malaria-a neurovascular pathology with many riddles still to be solved. Coltel N, Combes V, Hunt NH, Grau GE, Curr Neurovasc Res 2004 1 91 110 10.2174/1567202043480116 16185187
17. Erythropoietin treatment improves neurological functional recovery in EAE mice. Zhang J, Li Y, Cui Y, Chen J, Lu M, Elias SB, Chopp M, Brain Res 2005 1034 34 39 10.1016/j.brainres.2004.11.036 15713257
18. Recombinant human erythropoietin prevents the death of mice during cerebral malaria. Kaiser K, Texier A, Ferrandiz J, Buguet A, Meiller A, Latour C, Peyron F, Cespuglio R, Picot S, J Infect Dis 2006 193 987 995 10.1086/500844 16518761
19. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Wiese L, Hempel C, Penkowa M, Kirkby N, Kurtzhals JA, Malar J 2008 7 3 10.1186/1475-2875-7-3 18179698
20. Plasmodium berghei ANKA: Erythropoietin activates neural stem cells in an experimental cerebral malaria model. Core A, Hempel C, Kurtzhals JA, Penkowa M, Exp Parasitol 2011 127 500 505 10.1016/j.exppara.2010.09.010 21044627
21. Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Wiese L, Kurtzhals JA, Penkowa M, Exp Neurol 2006 200 216 226 10.1016/j.expneurol.2006.02.011 16624296
22. Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. Penet MF, Viola A, Confort-Gouny S, Le FY, Duhamel G, Kober F, Ibarrola D, Izquierdo M, Coltel N, Gharib B, Grau GE, Cozzone PJ, J Neurosci 2005 25 7352 7358 10.1523/JNEUROSCI.1002-05.2005 16093385
23. Magnetic resonance features of cerebral malaria. Yadav P, Sharma R, Kumar S, Kumar U, Acta Radiol 2008 49 566 569 10.1080/02841850802020476 18568544
24. Erythropoietin enhances immune responses in mice. Katz O, Gil L, Lifshitz L, Prutchi-Sagiv S, Gassmann M, Mittelman M, Neumann D, Eur J Immunol 2007 37 1584 1593 10.1002/eji.200637025 17458859
25. Erythropoietin activates nitric oxide synthase in murine erythrocytes. Mihov D, Vogel J, Gassmann M, Bogdanova A, Am J Physiol Cell Physiol 2009 297 378 C388 10.1152/ajpcell.00543.2008 19515903
26. Topographical distribution of the cerebral lesions in mice infected with Plasmodium berghei. Polder T, Jerusalem C, Eling W, Tropenmed Parasitol 1983 34 235 243 6364514
27. Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia. Goldenberg-Cohen N, Guo Y, Margolis F, Cohen Y, Miller NR, Bernstein SL, Invest Ophthalmol Vis Sci 2005 46 2716 2725 10.1167/iovs.04-0547 16043843
28. Cardiac arrest-induced regional blood-brain barrier breakdown, edema formation and brain pathology: a light and electron microscopic study on a new model for neurodegeneration and neuroprotection in porcine brain. Sharma HS, Miclescu A, Wiklund L, J Neural Transm 2010 118 87 114 20963453
29. CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and reversed by erythropoietin. Hempel C, Combes V, Hunt NH, Lindholm Kurtzhals JA, Raymond Grau GE, Am J Pathol 2011 179 1939 1950 10.1016/j.ajpath.2011.06.027 21854739
30. The role of cerebral oedema in the pathogenesis of cerebral malaria. Sanni LA, Redox Rep 2001 6 137 142 10.1179/135100001101536238 11523587
31. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. Reis PA, Comim CM, Hermani F, Silva B, Barichello T, Portella AC, Gomes FC, Sab IM, Frutuoso VS, Oliveira MF, Bozza PT, Bozza FA, Dal-Pizzol F, Zimmerman GA, Quevedo J, Castro-Faria-Neto HC, PLoS Pathog 2010 6 1000963 10.1371/journal.ppat.1000963 20585569
32. Myelination of the mouse corpus callosum. Sturrock RR, Neuropathol Appl Neurobiol 1980 6 415 420 10.1111/j.1365-2990.1980.tb00219.x 7453945
33. Inflammation stimulates remyelination in areas of chronic demyelination. Foote AK, Blakemore WF, Brain 2005 128 528 539 10.1093/brain/awh417 15699059
34. Erythropoietin amplifies stroke-induced oligodendrogenesis in the rat. Zhang L, Chopp M, Zhang RL, Wang L, Zhang J, Wang Y, Toh Y, Santra M, Lu M, Zhang ZG, PLoS One 2010 5 11016 10.1371/journal.pone.0011016 20552017
35. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Wakita H, Tomimoto H, Akiguchi I, Matsuo A, Lin JX, Ihara M, McGeer PL, Brain Res 2002 924 63 70 10.1016/S0006-8993(01) 03223-1 11743996
36. T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis. Shriver LP, Dittel BN, Am J Pathol 2006 169 999 1011 10.2353/ajpath.2006.050791 16936273
37. Retinal pathology of pediatric cerebral malaria in Malawi. White VA, Lewallen S, Beare NA, Molyneux ME, Taylor TE, PLoS One 2009 4 4317 10.1371/journal.pone.0004317 19177166
38. Erythropoietin gene expression in human, monkey and murine brain. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassmann M, Eur J Neurosci 1996 8 666 676 10.1111/j.1460-9568.1996.tb01252.x 9081618
39. In vivo evidence that erythropoietin protects neurons from ischemic damage. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R, Proc Natl Acad Sci U S A 1998 95 4635 4640 10.1073/pnas.95.8.4635 9539790
40. Cytokines and adhesion molecules expression in the brain in human cerebral malaria. Armah H, Wired EK, Dodoo AK, Adjei AA, Tettey Y, Gyasi R, Int J Environ Res Public Health 2005 2 1 123 131 10.3390/ijerph2005010123 16705810
41. Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei. Polder TW, Eling WM, Curfs JH, Jerusalem CR, Wijers-Rouw M, Acta Leiden 1992 60 31 46 1485495
42. Ultrastructural changes in the capillary bed of the rat cerebral cortex in anoxic-ischemic brain lesions. Hills CP, Am J Pathol 1964 44 531 551 5877504
43. Erythropoietin prevents blood brain barrier damage induced by focal cerebral ischemia in mice. Li Y, Lu ZY, Ogle M, Wei L, Neurochem Res 2007 32 2132 2141 10.1007/s11064-007-9387-9 17562165
44. Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique. Neill AL, Chan-Ling T, Hunt NH, Parasitology 1993 107 477 487 10.1017/S0031182000068050 8295787
45. Cerebral malaria. A disseminated vasculomyelinopathy. Toro G, Roman G, Arch Neurol 1978 35 271 275 10.1001/archneur.1978.00500290017004 348169
46. A light and electron microscopic study of oedematous human cerebral cortex in two patients with post-traumatic seizures. Castejon OJ, Castejon HV, Zavala M, Sanchez ME, Diaz M, Brain Inj 2002 16 331 346 10.1080/ 02699050110088209 11953004
47. The development of the corpus callosum in cats: a light- and electron-microscopic study. Berbel P, Innocenti GM, J Comp Neurol 1988 276 132 156 10.1002/cne.902760109 3192762
48. Species differences and similarities in the fine structure of the mammalian corpus callosum. Olivares R, Montiel J, Aboitiz F, Brain Behav Evol 2001 57 98 105 10.1159/000047229 11435670
49. Pseudobulbar paralysis-a sequelae of cerebral malaria. Mohapatra MK, Sethy G, Mohanty SC, J Assoc Physicians India 2004 52 324 325 15636339
50. Can erythropoietin be used to prevent brain damage in cerebral malaria? Casals-Pascual C, Idro R, Picot S, Roberts DJ, Newton CR, Trends Parasitol 2009 25 30 36 10.1016/j.pt.2008.10.002 19008152
51. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. de Souza JB, Hafalla JC, Riley EM, Couper KN, Parasitology 2010 137 755 772 10.1017/S0031182009991715 20028608
52. High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Casals-Pascual C, Idro R, Gicheru N, Gwer S, Kitsao B, Gitau E, Mwakesi R, Roberts DJ, Newton CR, Proc Natl Acad Sci U S A 2008 105 2634 2639 10.1073/pnas.0709715105 18263734
53. Safety of epoetin beta-quinine drug combination in children with cerebral malaria in Mali. Picot S, Bienvenu AL, Konate S, Sissoko S, Barri A, Diarra E, Bamba K, Djimde A, Doumbo OK, Malar J 2009 8 169 10.1186/1475-2875-8-169 19630971